196202-72-9Relevant articles and documents
Development of new non-peptide GPIIb-IIIa antagnosts, NSL-95315 and NSL-95317, isosteres of NSL-95300
Asari, Tohru,Ishikawa, Shigetaka,Sasaki, Toshiki,Katada, Jun,Hayashi, Yoshio,Harada, Takeo,Yano, Mako,Yasuda, Emiko,Uno, Isao,Ojima, Iwao
, p. 2099 - 2104 (2007/10/03)
The synthetic and structure-activity relationship (SAR) studies of new non-peptide GPIIb/IIIa antagonists (1a-f and 3) were conducted by replacing one amide bond of NSL-95300 (2) with an (E)-double bond or an enone group. NSL-95315 (1a) and NSL-95317 (3) showed the inhibitory activity for collagen-induced human platelet aggregation with IC50 values of 0.25 μM and 0.21 μM, respectively.